Arrowhead Pharmaceuticals announces $500M strategic financing facility with Sixth Street

2024-08-09 04:24

Arrowhead Pharmaceuticals (NASDAQ:ARWR) on Thursday said it has entered into a strategic financing agreement with Sixth Street for significant, long-term, non-dilutive capital to fund innovation and growth opportunities across Arrowhead’s robust and diverse pipeline of RNAi therapeutics.
The $500 million senior secured credit facility includes $400 million funded at close with an additional $100 million available at Arrowhead’s option.
The credit facility matures on August 7, 2031, and bears interest at an annual rate of 15%.
ARWR -2.12% after hours to $25.3.
Source: Press Release

More on Arrowhead Pharmaceuticals